From BLISS to ILLUMINATE studies: "Blys repetita placent"?
- PMID: 26487652
- DOI: 10.1136/annrheumdis-2015-208702
From BLISS to ILLUMINATE studies: "Blys repetita placent"?
Keywords: Disease Activity; Systemic Lupus Erythematosus; Treatment.
Comment in
-
Further thoughts about the ILLUMINATE studies of tabalumab in SLE.Ann Rheum Dis. 2016 Feb;75(2):e11. doi: 10.1136/annrheumdis-2015-208709. Epub 2015 Nov 3. Ann Rheum Dis. 2016. PMID: 26530320 No abstract available.
Comment on
-
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.Ann Rheum Dis. 2016 Feb;75(2):323-31. doi: 10.1136/annrheumdis-2015-207653. Epub 2015 Sep 3. Ann Rheum Dis. 2016. PMID: 26338095 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical